Biomimetic Surface Engineering Strategies for Enhanced Osseointegration and Peri-Implant Bone Regeneration: A Systematic Review
Biomimetics · 02.07.2026 · 11 (7) · 460
DOI: 10.3390/biomimetics11070460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomimetics, online erschienen am 02.07.2026. Verfasst von Fatma Karacaoğlu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Faculty of Dentistry, Ankara University, Yenimahalle, Ankara 06560, Turkey. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This systematic review aimed to evaluate the effects of biomimetic surface engineering strategies applied to dental implants on osseointegration and peri-implant bone regeneration compared with conventional implant surfaces. Materials and Methods: A comprehensive literature search was conducted in the Web of Science, PubMed, and Scopus databases in accordance with the PRISMA guidelines, covering the period from January 2021 to January 2026. A total of 12 studies, including in vivo animal experiments and in vitro investigations, that met the inclusion criteria were analyzed. Risk of bias assessment was performed using the SYR-CLE tool and the ARRIVE guidelines.
Results
Biomimetic strategies, including laser texturing, sulfonation, bioactive coatings, and growth factor/peptide functionalization (e.g., BMP-2, FGF-2, and PRF), significantly increased bone–implant contact (BIC), new bone volume (BV/TV), and biomechanical stability (pullout strength and reverse torque) compared to conventional surfaces. These surfaces enhance fixation under conditions of low bone density, such as osteoporosis, and improve infection resistance through antibacterial activity. In addition, these modifications enhance cellular adhesion, osteogenic differentiation, angiogenesis, and immune modulation.
Conclusions
Current experimental evidence suggests that biomimetic implant surface engineering transforms dental implants from passive biomaterials into multifunctional bioactive interfaces capable of simultaneously regulating osteogenesis, immune response, angiogenesis, and antibacterial activity. Although promising outcomes have been demonstrated in preclinical studies, standardized long-term human clinical studies are still required to validate translational potential and long-term clinical efficacy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Periodontology, Faculty of Dentistry, Ankara University, Yenimahalle, Ankara 06560, Turkey.
- Department of Periodontology, Faculty of Dentistry, Bozok University, Yozgat 66100, Turkey.
- Department of Dento Maxillofacial Radiology, Faculty of Dentistry, Ankara University, Yenimahalle, Ankara 06560, Turkey.
- Ankara University Medical Design Application and Research Center (MEDITAM), Ankara University, Ankara 06010, Turkey.
- Department of Oral Radiology, School and Hospital of Stomatology, Cheeloo College of Medicine, Shandong University, Jinan 250012, China.
ORCID-Profile: Zülal Deniz Güner, Merter Güçlü, Kaan Orhan
Zitieren
APA
Karacaoğlu, F., Güner, Z. D., Güçlü, M., Özer, E. D., Bağış, N., & Orhan, K. (2026). Biomimetic Surface Engineering Strategies for Enhanced Osseointegration and Peri-Implant Bone Regeneration: A Systematic Review. Biomimetics, 11(7), 460. https://doi.org/10.3390/biomimetics11070460
Vancouver
Karacaoğlu F, Güner ZD, Güçlü M, Özer ED, Bağış N, Orhan K. Biomimetic Surface Engineering Strategies for Enhanced Osseointegration and Peri-Implant Bone Regeneration: A Systematic Review. Biomimetics. 2026;11(7):460. doi:10.3390/biomimetics11070460
BibTeX
@article{Karacaolu2026,
author = {Karacaoğlu, Fatma and Güner, Zülal Deniz and Güçlü, Merter and Özer, Elif Didem and Bağış, Nilsun and Orhan, Kaan},
title = {Biomimetic Surface Engineering Strategies for Enhanced Osseointegration and Peri-Implant Bone Regeneration: A Systematic Review},
journal = {Biomimetics},
year = {2026},
volume = {11},
number = {7},
pages = {460},
doi = {10.3390/biomimetics11070460}
}
EUVIMED